Ján Murín, Jozef Bulas, Martin Wawruch
Patients discharged from the hospital after STEMI are usually seriously ill. The main risk parameters of their increased
morbidity and mortality are: recurrent ischemia, ventricular arrhythmia and heart failure.
Patients are discharged when clinically stable. They should be educated about myocardial infarction and about secondary
prevention and treatment. Before discharge, ”risk stratification“ is carried out on the patients, and they are
given pharmacotherapy: ACE inhibitor, betablocker, statin (usually a strong one, and in a highest dose possible),
and aspirin, too. Sometimes, there is a need to uptitrate the dose of ACE inhibitor and betablocker.